Loading …

Calli Biotech is an Australian biopharmaceutical company dedicated to developing innovative cancer therapies, bringing together the power of the immune system and the induction of apoptosis to generate improved patient outcomes.
Annual Revenue$1M to $5M
Estimated OwnershipPrivateBuilt from contact records that share this company: name, job title, job level, job function and person location.
Turn cold outreach into meaningful business conversations.
Rated and recommended by professionals who expect more
Matching runs on fields we already have: industry, employee range, HQ location, ownership type, funding rounds, specialities. Results come live from the ReachStream directory.